BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 18261245)

  • 21. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
    Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
    Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation sensitivity as a moderator of communication disorder in schizophrenia.
    Grant PM; Beck AT
    Psychol Med; 2009 Jul; 39(7):1211-9. PubMed ID: 19379529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Attention models in evaluating schizophrenia].
    Bernard D; Lançon C; Bougerol T
    Encephale; 1997; 23(2):113-8. PubMed ID: 9264930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correspondences between theory of mind, jumping to conclusions, neuropsychological measures and the symptoms of schizophrenia.
    Woodward TS; Mizrahi R; Menon M; Christensen BK
    Psychiatry Res; 2009 Dec; 170(2-3):119-23. PubMed ID: 19906438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentionality as a link between the neuropsychology and the symptoms of schizophrenia.
    Kaiser S; Weisbrod M
    Psychopathology; 2007; 40(4):221-8. PubMed ID: 17396048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive deficit in schizophrenia: comparative analysis of positive and negative subtype and predictors of positive subtype.
    Cvetić T; Vuković O
    Psychiatr Danub; 2006 Jun; 18(1-2):4-11. PubMed ID: 16804494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affective modulation of external misattribution bias in source monitoring in schizophrenia.
    Costafreda SG; Brébion G; Allen P; McGuire PK; Fu CH
    Psychol Med; 2008 Jun; 38(6):821-4. PubMed ID: 18377674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive functions in bipolar affective disorder and schizophrenia: comparison.
    Pradhan BK; Chakrabarti S; Nehra R; Mankotia A
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):515-25. PubMed ID: 18950370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formal thought disorder, neuropsychology and insight in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychopathology; 2009; 42(4):264-9. PubMed ID: 19521143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels.
    Karilampi U; Helldin L; Hjärthag F; Norlander T; Archer T
    Arch Clin Neuropsychol; 2007 Feb; 22(2):161-74. PubMed ID: 17241763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
    Bryson G; Bell M; Greig T; Kaplan E
    Schizophr Res; 1999 Jul; 38(1):27-35. PubMed ID: 10427608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia].
    Johnson I; Ben Azouz O; Kebir O; Dellagi L; Amado I; Tabbane K
    Tunis Med; 2009 Oct; 87(10):664-9. PubMed ID: 20187354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stability of positive/negative symptoms in schizophrenia].
    Ribeyre JM; Dollfus S
    Encephale; 1996 Jun; 22 Spec No 2():29-31. PubMed ID: 8767039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative symptoms: relationship to other schizophrenic symptom classes.
    McKenna PJ; Lund CE; Mortimer AM
    Br J Psychiatry Suppl; 1989 Nov; (7):104-7. PubMed ID: 2619978
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive correlates of schizophrenia signs and symptoms: III. Hallucinations and delusions.
    Berenbaum H; Kerns JG; Vernon LL; Gomez JJ
    Psychiatry Res; 2008 May; 159(1-2):163-6. PubMed ID: 18423619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.